This question tests understanding of adverse effects and drug interactions, particularly angioedema from ACE inhibitors. The key findings are swelling of lips and tongue with difficulty swallowing shortly after starting enalapril, indicating angioedema. Immediate intervention is required to prevent airway obstruction. Dizziness, dry cough, and slightly elevated BP are common and less urgent. Assessment of airway patency is vital. The nursing process prioritizes emergency response. A transferable strategy is to monitor for angioedema in the first weeks of ACE inhibitor therapy.

This question tests understanding of adverse effects and drug interactions. The key assessment findings include the client's recent use of sildenafil, prescription for nitroglycerin, low blood pressure of 96/58 mmHg, heart rate of 92/min, and dizziness upon standing, indicating potential orthostatic hypotension. The correct answer, option A, is the best choice because sildenafil and nitroglycerin both cause vasodilation, which can lead to severe hypotension, prioritizing client safety by instructing avoidance of nitroglycerin and notifying the provider for alternative management. Option B is incorrect as administering nitroglycerin could worsen hypotension and driving to the pharmacy is unsafe given the client's symptoms; option C is wrong because sildenafil is not indicated for preventing chest pain and daily use is inappropriate; option D is less optimal as continuing both medications ignores the dangerous interaction, and increasing fluids does not address the root cause of the risk. In the nursing process, this involves thorough assessment of medication history and vital signs to identify interactions, followed by immediate intervention to prevent adverse events. Decision-making in medication safety requires prioritizing actions that mitigate life-threatening risks like severe hypotension. A transferable strategy for managing medication-related issues is to routinely educate clients on potential drug interactions and encourage them to report all medications to healthcare providers before starting new prescriptions.

This question tests understanding of adverse effects and drug interactions, focusing on beta-blockers antagonizing beta-agonists in COPD. The key symptoms are increased shortness of breath and wheezing unrelieved by albuterol in a client on propranolol, due to bronchoconstriction. Questioning propranolol in a COPD client using albuterol is appropriate as nonselective beta-blockers worsen symptoms. Albuterol, corticosteroids, and saline are standard. Assessment of respiratory response is essential. The nursing process emphasizes evaluating therapy efficacy. A transferable strategy is to use cardioselective beta-blockers in respiratory conditions.

This question tests understanding of adverse effects and drug interactions, specifically anticholinergic effects counteracting cholinesterase inhibitors. The key findings are increased confusion, dry mouth, and constipation in a client on donepezil and oxybutynin, indicating antagonism. Notifying the provider that oxybutynin may worsen cognition and counteract donepezil is priority for safety and symptom management. Increasing donepezil risks side effects; limiting fluids worsens constipation; sleep aids add anticholinergics. Assessment of cognitive changes is key. The decision-making principle is to avoid opposing mechanisms. A transferable strategy is to review anticholinergic burden in dementia clients.

This question tests understanding of adverse effects and drug interactions, particularly reduced contraceptive efficacy from enzyme inducers. The key concern is breakthrough bleeding and pregnancy risk in a client on oral contraceptives and rifampin, due to induced metabolism. Teaching to use backup contraception is priority to prevent unintended pregnancy safely. Reassuring increased effectiveness is incorrect; stopping rifampin risks TB; doubling dose is unsafe without orders. Assessment involves recognizing interaction effects. The decision-making principle is client education on risks. A transferable strategy is to counsel on alternative contraception with inducers.

This question tests understanding of adverse effects and drug interactions, particularly digoxin toxicity exacerbated by hypokalemia from diuretics. The key findings are nausea, visual halos, bradycardia, and low potassium in a client on digoxin and furosemide, signaling toxicity. Holding digoxin and notifying the provider is priority to prevent arrhythmias and address hypokalemia safely. Administering digoxin worsens toxicity; restricting fluids is inappropriate; antacids don't address the cause. Assessment of electrolyte and cardiac status is vital. The decision-making principle is to withhold drugs in toxicity signs. A transferable strategy is to monitor potassium levels when using digoxin with loop diuretics.

This question tests understanding of adverse effects and drug interactions, particularly respiratory depression from opioid-benzodiazepine combinations. The key findings are difficulty arousing, slurred speech, bradypnea, and low SpO2 in a client on oxycodone and lorazepam, suggesting sedation overdose. Holding sedating medications, supporting ventilation, and notifying the provider or rapid response team is priority to prevent respiratory arrest. Ambulating may increase fall risk; offering a snack addresses hypoglycemia not indicated; administering more lorazepam worsens sedation. Assessment of respiratory status is crucial in polypharmacy. The decision-making principle is to prioritize reversal of life-threatening effects. A transferable strategy is to monitor sedation levels when combining CNS depressants.

This question tests understanding of adverse effects and drug interactions, particularly additive bradycardia and hypotension from beta-blockers and calcium channel blockers. The key findings are lightheadedness, hypotension, and bradycardia in a client on metoprolol and diltiazem, indicating hemodynamic compromise. Holding doses and notifying the provider is priority to prevent syncope or shock. Giving more metoprolol worsens effects; caffeine is inappropriate; reassessing later delays care. Assessment of vital signs is essential. The decision-making principle is to avoid additive AV node suppression. A transferable strategy is to monitor heart rate closely with combined rate controllers.

This question tests understanding of adverse effects and drug interactions, focusing on hyperkalemia from ACE inhibitors and certain antibiotics. The key finding is elevated potassium with weakness in a client on lisinopril and trimethoprim-sulfamethoxazole, especially with kidney disease. Questioning trimethoprim-sulfamethoxazole added to lisinopril is appropriate as this combination risks hyperkalemia. Mupirocin, acetaminophen, and polyethylene glycol are safe. Assessment of electrolytes in renal clients is essential. The nursing process prioritizes lab monitoring. A transferable strategy is to choose alternative antibiotics in hyperkalemia risk.

This question tests understanding of adverse effects and drug interactions, specifically bone marrow suppression from azathioprine potentiated by allopurinol. The key findings are fever, sore throat, and low WBC in a client on allopurinol and azathioprine, indicating myelosuppression. Questioning azathioprine with allopurinol is appropriate as this interaction increases toxicity risk. Calcium, docusate, and hydrocortisone are safe. Assessment of blood counts is vital in immunosuppression. The nursing process prioritizes infection signs. A transferable strategy is to dose-adjust immunosuppressants with xanthine oxidase inhibitors.